Saïd Business School, University of Oxford, Oxford, UK.
School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, The University of Dublin, Dublin, Ireland; Centre for Pharmaceutical Medicine Research, Kings College London, London, UK.
Soc Sci Med. 2024 Nov;360:117301. doi: 10.1016/j.socscimed.2024.117301. Epub 2024 Sep 10.
The healthcare sector has increasingly adopted digital innovations. Nonetheless, medical professionals have also resisted a variety of digital innovations. While the range of factors driving such resistance to innovation are well documented, less clear is how such resistance is experienced and managed by professionals attempting to innovate. We conducted a qualitative study of English and German 'dual-role' professionals, who worked both as clinical practitioners and digital innovators. Inductively theorizing from our interview data, we explain how individual professionals experience different intensities of stigmatization from colleagues when working with digital innovations. We theorize that the more central a dual-role professional is within an organization and the more their innovation deviates from standard professional duties, the more likely the innovation is to be viewed as impure within a professional group and be the target of stigmatization. We identify a range of professional, social, and personal strategies employed by dual-role innovators to manage their experiences of stigmatization and consider the implications for healthcare innovation.
医疗保健领域越来越多地采用数字创新。尽管如此，医疗专业人员也抵制了各种数字创新。虽然推动这种创新抵制的因素范围已经有充分的记录，但不太清楚的是，试图创新的专业人员是如何体验和管理这种抵制的。我们对英国和德国的“双重角色”专业人员进行了一项定性研究，这些专业人员既是临床医生，也是数字创新者。我们从访谈数据中进行归纳理论分析，解释了个体专业人员在使用数字创新时如何经历来自同事的不同程度的污名化。我们的理论是，双重角色的专业人员在组织中的核心地位越高，他们的创新与标准专业职责的偏离程度越大，那么这项创新就越有可能被视为专业群体内部的不纯洁，并成为污名化的目标。我们确定了双重角色创新者用来管理其污名化体验的一系列专业、社会和个人策略，并考虑了这些策略对医疗保健创新的影响。
